Abstract:To develop a new interventional oncology technique, "radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus thymidine kinase (GFP/HSV-TK)/ganciclovir (GCV) gene therapy of cholangiocarcinoma." Luciferase/mCherry-labeled cholangiocarcinoma cells and 24 mice with subcutaneously implanted cholangiocarcinoma cells were treated by: (i) a combination of green fluorescent protein (GFP)/HSV-TK/plasmid gene transfection followed by RFH and ganciclovir exposure; (ii) gene therapy alone; (iii) RFH alone; and (iv) phosphate-buffered saline (PBS) to serve as a control (6 mice per group). Cell viabilities were quantified by MTS assay. Bioluminescent optical imaging and transcutaneous ultrasound imaging were used to follow up the tumor growth over 2 weeks. For in-vivo technical validation of the new technique, pigs in two groups received either intrabiliary delivery of GFP/HSV-TK/plasmid using a needle-integrated balloon catheter flowed by RFH enhancement (n = 6) or gene delivery only (n = 6). GFP signal in bile duct walls were quantified by optical imaging.The non- parametric Mann-Whitney U test was used for statistical comparison of variables. MTS assay demonstrated the lowest cell proliferation in combination therapy compared with three control groups (24.0 ± 5.3% vs 41.9 ± 6.4% vs 72.0 ± 9.0% vs 100%, p<0.001). GFP optical imaging confirmed that GFP/HSV-TK gene expression peaked at day 2 after gene transfection. Bioluminescent optical imaging demonstrated the decreased bioluminescence signals in tumors of combination therapy, compared with other control groups (0.71 ± 0.16 vs 1.46 ± 0.21 vs 2.10 ± 0.27 vs 2.36 ± 0.28, p<0.001). Ultrasound imaging showed the smallest tumor volumes of the combination therapy group, compared with other groups (0.90 ± 0.21 VS 1.61 ± 0.21 VS 2.22 ± 0.25 VS 2.50 ± 0.30, p<0.001). optical imaging confirmed higher GFP expression in the bile ducts with RFH enhancement (signal to noise ratio: 1.28 ± 0.61 VS 0.49 ± 0.31, P<0.05). It is feasible to use intratumoral RFH to enhance GFP/HSV-TK/plasmid gene expression and HSV-TK/GCV gene therapy of cholangiocarcinomas.This concept may pave a new avenue for managing pancreatobiliary malignancies.(supported by an NIH RO1EBO12467)

Establishment and characterization of McA-RH7777 cells using virus-mediated stable overexpression of enhanced green fluorescent protein.

Establishment of Green Fluorescent Protein-Expressing Hepatocellular Carcinoma Cell Lines with Different Metastatic Potential: Relevant Models for in Vivo Monitoring of Metastasis and Angiogenesis

Establishment of Green Fluorescent Protein-Expressing Hepatocellular Carcinoma Cell Lines MHCC97-HG/ LG with Different Metastatic Potentials

Establishment of stable fluorescent protein-expressing hepatocellular carcinoma xenograft model in nude mice

Screen of time window of stable expression of enhanced green fluorescent for transplanted hepatocellular carcinoma in Buffalo rats

Establishment and characteristic of an orthotopic implantation model of human hepatocellular carcinoma with Luc-GFP-labeled in nude mice

Establishment of Orthotopic Lung Cancer Model Expressing Enhanced Green Fluorescent Protein

Modeling Liver Metastasis Using a Tumor Cell Line Derived from an Enhanced Green Fluorescent Protein Transgenic Mouse.

Biological Characteristics of Fluorescent Protein-Expressing Human Hepatocellular Carcinoma Xenograft Model in Nude Mice

Establishment of a Dual-Color Fluorescence Tracing Orthotopic Transplantation Model of Hepatocellular Carcinoma.

Intrabiliary Radiofrequency Heating-Enhanced Direct Intratumoral GFP/HSV-TK Gene Therapy of Cholangiocarcinoma: A Preclinical Study on Mice and Pigs

THE ENHANCED GREEN FLUORESCENT PROTEIN AS A MARKER FOR HUMAN TUMOR CELLS LABELLED BY RETROVIRAL TRANSDUCTION

Construction and Characterization of Stable Β1-Integrin-gfp Fusion Gene Overexpressing HCC Cell Lines

Establishment of an Orthotopic Transplantation Tumor Model of Hepatocellular Carcinoma in Mice.

Establishment, identificaton and biological features of stably CXCL1 transfected human hepatocellular carcinoma cells

Establishment and application of eGFP gene marked tumor cells model in murine

Construction and Expression of Eukaryotic Expression Vector for Hepatitis B Virus X Gene Containing EGFP

Establishment of a Murine Model with Ehcg#beta# Transfected Tumor Cells

Establishment of a Gastric Cancer Cell Line Marked by Green Fluorescent Protein

Establishment of an Intrahepatic Xenograft Tumor Model in Nude Mice and Its Detection by in Vivo Fluorescence Imaging System

Human liver cancer high-transfer cell strain with stable expression of fluorescent protein and construction method thereof